Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271245 · ClinicalTrials.gov registry record · NA
Selenium Supplementation of Patients With Cirrhosis
A NA study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT00271245 is a NA study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 99 participants.
The verdict
NCT00271245, a NA study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether patients with liver cirrhosis can improve their selenium nutritional status by taking supplemental selenium.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT 200 µg selenium as selenate
- DIETARY_SUPPLEMENT 400 µg selenium as selenate
- DIETARY_SUPPLEMENT 200 µg selenium as selenomethionine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2006-02 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00271245
The ClinicalTrials.gov registry entry for NCT00271245 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00271245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00271245 about?
NCT00271245 is a clinical study titled "Selenium Supplementation of Patients With Cirrhosis". The purpose of this study is to determine whether patients with liver cirrhosis can improve their selenium nutritional status by taking supplemental selenium.
What is the current status of trial NCT00271245?
This trial is currently terminated. It is a NA study. The enrollment target is 99 participants. The study started on 2006-02. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00271245?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), 200 µg selenium as selenate (DIETARY_SUPPLEMENT), 400 µg selenium as selenate (DIETARY_SUPPLEMENT), 200 µg selenium as selenomethionine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00271245?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.